dc.contributorUniversidade de Brasília (UnB)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:24:27Z
dc.date.available2014-05-20T13:24:27Z
dc.date.created2014-05-20T13:24:27Z
dc.date.issued2004-07-01
dc.identifierCurrent Drug Targets. Hilversum: Bentham Science Publ Ltd, v. 5, n. 5, p. 449-455, 2004.
dc.identifier1389-4501
dc.identifierhttp://hdl.handle.net/11449/7585
dc.identifier10.2174/1389450043345407
dc.identifierWOS:000221917500006
dc.description.abstractDrug delivery systems are essential components of drugs controlled release. In the last decades, several drug delivery technologies have emerged including capsules, liposomes. microparticles, nanoparticles, and polymers. These components must be biocompatible, biodegradable, and display a desired biodistribution providing a long-term availability of the therapeutic at specific target over time.
dc.languageeng
dc.publisherBentham Science Publ Ltd
dc.relationCurrent Drug Targets
dc.relation3.112
dc.relation0,906
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectdrug design
dc.subjectmicrotechnology
dc.subjectnanotechnology
dc.subjectnanospheres
dc.subjectnanocapsules
dc.subjectantibody-based drug delivery
dc.titleDrug delivery systems: Past, present, and future
dc.typeOtros


Este ítem pertenece a la siguiente institución